Gender Dysphoria in Adolescents and Adults: Symptoms, Diagnosis, and Evidence-Based Treatment

Gender dysphoria refers to the clinically significant distress or functional impairment that arises when a person's experienced or expressed gender differs markedly from their assigned gender at birth. It is important to understand that gender diversity itself is not a mental disorder. The DSM-5-TR classifies gender dysphoria as a diagnostic category specifically to identify and address the distress that can accompany this incongruence — not to pathologize gender identity itself.

The term replaced the older diagnosis of "gender identity disorder" in 2013 with the publication of the DSM-5, reflecting a deliberate shift in clinical understanding. The focus moved away from treating gender nonconformity as inherently disordered and toward recognizing that the suffering associated with the mismatch between experienced gender and assigned sex is what warrants clinical attention and, often, intervention.

Gender dysphoria can manifest across the lifespan. In adolescents and adults, it frequently involves a persistent, deeply felt sense that one's body does not align with one's gender identity, accompanied by a strong desire to live as and be recognized as a gender different from the one assigned at birth. Some individuals experience dysphoria primarily related to physical sex characteristics (such as chest, genitalia, or secondary sex characteristics), while others experience it more acutely in social contexts — being addressed by the wrong pronouns, being perceived as the wrong gender, or being forced into gendered roles that feel fundamentally wrong.

The World Health Organization (WHO) took a parallel step in the ICD-11 (2019), reclassifying the condition as gender incongruence and moving it out of the mental disorders chapter entirely, placing it instead under "conditions related to sexual health." This change was made to reduce stigma while preserving access to healthcare services.

Estimating the prevalence of gender dysphoria is challenging because figures depend on how the condition is defined and measured — whether by formal clinical diagnosis, self-reported gender incongruence, or transgender identity more broadly. Prevalence estimates have increased substantially over the past two decades, likely reflecting greater social awareness, reduced stigma, and improved access to healthcare rather than a true increase in the underlying phenomenon.

The DSM-5-TR reports prevalence rates for adults based on those who present to specialty clinics. These estimates range from approximately 0.005% to 0.014% for individuals assigned male at birth and 0.002% to 0.003% for individuals assigned female at birth. However, these figures are widely considered to undercount the true population because they capture only those who seek specialized care.

Population-based surveys suggest significantly higher rates. Research published in recent years estimates that 0.3% to 0.6% of adults identify as transgender, and among adolescents, some surveys report rates of 1.2% to 2.7% identifying as transgender or gender diverse. The National Institutes of Health (NIH) and studies using data from the Behavioral Risk Factor Surveillance System (BRFSS) have produced estimates in these ranges.

A notable demographic shift has been observed in clinic referrals: historically, more individuals assigned male at birth sought services for gender dysphoria, but since approximately 2010, referrals of adolescents assigned female at birth have increased substantially in many Western countries. The reasons for this shift are actively debated in the clinical literature.

The DSM-5-TR provides separate diagnostic criteria for gender dysphoria in adolescents and adults (as distinct from the criteria for children). To meet the diagnosis, an individual must experience a marked incongruence between their experienced/expressed gender and their assigned gender, lasting at least six months, as manifested by at least two of the following:

• A marked incongruence between one's experienced/expressed gender and primary and/or secondary sex characteristics (or in young adolescents, the anticipated secondary sex characteristics)
• A strong desire to be rid of one's primary and/or secondary sex characteristics because of a marked incongruence with one's experienced/expressed gender (or in young adolescents, a desire to prevent the development of the anticipated secondary sex characteristics)
• A strong desire for the primary and/or secondary sex characteristics of the other gender
• A strong desire to be of the other gender (or some alternative gender different from one's assigned gender)
• A strong desire to be treated as the other gender (or some alternative gender different from one's assigned gender)
• A strong conviction that one has the typical feelings and reactions of the other gender (or some alternative gender different from one's assigned gender)

Critically, the condition must also be associated with clinically significant distress or impairment in social, occupational, or other important areas of functioning. This distress criterion is what distinguishes a clinical diagnosis from the broader experience of gender nonconformity, which does not inherently require treatment.

Clinicians should note that the DSM-5-TR uses the phrase "the other gender" but acknowledges that many individuals experience their gender identity outside the binary framework of male and female. Nonbinary, genderqueer, and gender-fluid identities are recognized within the clinical understanding of gender dysphoria.

Common signs and experiences — not all of which are required for diagnosis — include:

• Persistent discomfort when being addressed by one's birth name or pronouns associated with assigned gender
• Significant distress related to physical characteristics such as breast tissue, facial hair, voice pitch, or genital anatomy
• Avoidance of situations that call attention to one's body (e.g., locker rooms, swimming, intimate relationships)
• Social withdrawal, anxiety, or depression linked to the experience of gender incongruence
• Feeling a persistent sense of "wrongness" in one's body that has been present for months or years
• Binding, tucking, or other efforts to modify the appearance of sex characteristics

The development of gender identity — and the origins of gender dysphoria — are not fully understood, but the current scientific consensus points to a complex, multifactorial process involving biological, psychological, and social influences. No single cause has been identified, and it is most accurate to describe gender dysphoria as arising from the interplay of multiple factors.

Biological factors have received substantial research attention. Twin studies suggest a significant genetic component: concordance rates for gender identity are considerably higher in monozygotic (identical) twins compared to dizygotic (fraternal) twins, indicating that genetic factors contribute to the development of gender identity. Research has also explored the role of prenatal hormone exposure, particularly the effects of androgens on brain development during critical periods of fetal development. Studies of individuals with differences of sex development (DSD), such as congenital adrenal hyperplasia, provide indirect evidence that prenatal hormonal environments influence gender identity development.

Neuroimaging studies have found that certain brain structure and function patterns in transgender individuals show features that align more closely with their experienced gender than their assigned sex, though this research is still emerging and findings are not yet definitive or consistent enough to serve as diagnostic tools.

Psychological and social factors do not cause a person to be transgender, but they play important roles in how gender dysphoria is experienced and expressed. Social environment, cultural attitudes toward gender, family dynamics, and the availability of language and concepts for understanding gender diversity all influence when and how individuals recognize and express their gender identity. Environments that are hostile to gender diversity tend to intensify distress, while supportive environments are associated with better mental health outcomes.

It is essential to note that gender dysphoria is not caused by parenting style, childhood trauma, or social influence in any simple causal sense. While these factors can shape the timing and expression of gender identity exploration, the consistent finding across decades of research is that gender identity is deeply rooted and resistant to external attempts to change it.

Risk factors for distress (as distinct from risk factors for being transgender) include:

• Lack of family and social support
• Experiences of discrimination, bullying, or violence
• Minority stress — the chronic stress of belonging to a stigmatized group
• Barriers to accessing gender-affirming healthcare
• Co-occurring mental health conditions (which are often consequences of the above factors rather than independent causes)

Diagnosis of gender dysphoria is made through a comprehensive clinical evaluation conducted by a qualified mental health professional — typically a psychologist, psychiatrist, or clinical social worker with training in gender identity. There are no laboratory tests, brain scans, or genetic tests that diagnose gender dysphoria. The assessment is based on clinical interview, history-taking, and application of the DSM-5-TR criteria.

A thorough evaluation typically includes:

• Detailed history of gender identity development: When the individual first became aware of incongruence, how it has progressed over time, and how it has been expressed
• Assessment of current symptoms and distress: The nature, severity, and duration of dysphoria; how it affects daily functioning, relationships, work or school performance, and quality of life
• Mental health assessment: Screening for co-occurring conditions such as depression, anxiety, self-harm, and suicidality, which are common in individuals with gender dysphoria — particularly those without access to affirming care
• Exploration of the individual's goals: What the person hopes to achieve through treatment, whether that involves social transition, medical interventions, or other forms of support
• Differential diagnosis: Clinicians consider whether the presentation might be better explained by other conditions, such as body dysmorphic disorder, psychotic disorders involving delusions about one's body, or identity confusion related to other psychological processes. In practice, gender dysphoria is usually distinguishable from these conditions because the individual's experience is coherent, persistent, and specifically related to gender

For adolescents, the assessment process is often more extended and cautious, given the developmental changes occurring during puberty and the evolving nature of identity in younger populations. The World Professional Association for Transgender Health (WPATH) Standards of Care, Version 8, published in 2022, provides detailed guidance on assessment procedures for adolescents and emphasizes the importance of a developmentally informed, individualized approach.

It is worth emphasizing that the purpose of assessment is not to act as a gatekeeper or to determine whether someone is "truly" transgender. Rather, the goal is to confirm that the person's experience aligns with gender dysphoria, identify co-occurring conditions that need attention, ensure informed consent for any medical interventions, and support the individual in making decisions about their care.

Treatment for gender dysphoria is highly individualized and follows the principle of gender-affirming care — interventions designed to support and affirm an individual's gender identity. The evidence base for gender-affirming treatments has grown substantially over the past two decades, and multiple medical organizations — including the Endocrine Society, the American Medical Association, the American Psychological Association, and WPATH — support access to these treatments as medically necessary for many individuals with gender dysphoria.

Psychotherapy and Mental Health Support

Psychotherapy is not used to change or suppress a person's gender identity — such approaches, sometimes called "conversion therapy" or "reparative therapy," are rejected by every major medical and mental health organization as both ineffective and harmful. Instead, therapy serves several important roles:

• Helping individuals explore and understand their gender identity
• Providing support through the process of social or medical transition
• Addressing co-occurring conditions such as depression, anxiety, trauma, or substance use
• Building coping strategies for managing minority stress and discrimination
• Supporting family members in understanding and adjusting to their loved one's identity

Social Transition

Social transition involves living in alignment with one's gender identity without medical intervention. This can include changing one's name, pronouns, clothing, hairstyle, and social presentation. For many individuals, social transition provides substantial relief from dysphoria and is an essential component of care. Research consistently shows that social transition is associated with improved mental health outcomes.

Hormone Therapy

For adolescents and adults who desire medical transition, gender-affirming hormone therapy (GAHT) is one of the most well-studied and widely used interventions:

• Feminizing hormone therapy (estrogen, anti-androgens) promotes breast development, redistribution of body fat, softening of skin, and reduction of body hair
• Masculinizing hormone therapy (testosterone) promotes facial hair growth, voice deepening, redistribution of body fat, cessation of menstruation, and increased muscle mass

The Endocrine Society's 2017 Clinical Practice Guideline provides detailed protocols for hormone therapy. Research consistently demonstrates that hormone therapy is associated with reductions in gender dysphoria, improvements in psychological well-being, and enhanced quality of life. A large prospective study published in The New England Journal of Medicine (2023) found significant improvements in depression, anxiety, and life satisfaction among individuals receiving gender-affirming hormones over a two-year period.

Puberty Suppression in Adolescents

For adolescents in early puberty, gonadotropin-releasing hormone (GnRH) agonists — commonly called puberty blockers — can be used to pause the development of secondary sex characteristics. This intervention is considered reversible and provides additional time for the adolescent and their clinical team to make decisions about further treatment. The use of puberty blockers in adolescents has been the subject of significant clinical debate, with some countries adopting more restrictive approaches pending further long-term outcome data. The evidence base, while supportive of benefits in appropriately assessed individuals, continues to evolve.

Surgical Interventions

Gender-affirming surgeries — including chest reconstruction ("top surgery"), genital reconstruction ("bottom surgery"), facial feminization surgery, and other procedures — are considered medically necessary treatments for some individuals with gender dysphoria. WPATH Standards of Care, Version 8, provides criteria for surgical referral. Research on surgical outcomes consistently reports high satisfaction rates (typically above 94–97% in published studies) and significant reductions in dysphoria.

Voice and Communication Therapy

Speech-language pathologists with specialized training can help individuals modify their voice and communication patterns to align with their gender identity. This can be an important component of transition for individuals whose voice is a source of dysphoria.

The prognosis for individuals with gender dysphoria who receive appropriate, gender-affirming care is generally positive. Research consistently demonstrates that access to affirming medical and psychosocial interventions is associated with significant improvements in mental health, quality of life, and overall functioning.

Key findings from the research literature include:

• Mental health improvement: Multiple systematic reviews and meta-analyses report that gender-affirming hormone therapy and surgical interventions are associated with reduced depression, reduced anxiety, and improved overall psychological well-being. A 2021 meta-analysis published in JAMA Surgery found that gender-affirming surgery was associated with reduced need for mental health treatment and improved mental health outcomes.
• Low regret rates: Studies consistently find that regret after gender-affirming medical interventions is uncommon. A systematic review of surgical outcomes estimated regret rates at approximately 1% or lower, with many studies reporting rates below 0.5%. Regret, when it occurs, is more often related to surgical complications or poor social outcomes than to identity-related reconsideration.
• Social support as a key moderator: Individuals with strong family support, community acceptance, and legal protections for their gender identity consistently show better outcomes than those who face rejection and discrimination. Family acceptance is one of the strongest predictors of positive mental health outcomes, particularly for adolescents.
• Persistent disparities: Despite improvements with treatment, transgender and gender diverse individuals continue to experience elevated rates of depression, anxiety, and suicidality compared to the general population. These disparities are attributable primarily to minority stress — the cumulative impact of stigma, discrimination, violence, and systemic barriers — rather than to gender identity itself.

For adolescents specifically, long-term outcome data are more limited than for adults, and this is an active area of research. Early studies of adolescents who underwent puberty suppression followed by hormone therapy reported improved psychological functioning in young adulthood, but clinicians and researchers acknowledge the need for longer follow-up periods and larger samples.

Without treatment, gender dysphoria is associated with significant psychological suffering. Rates of suicidal ideation and suicide attempts are markedly elevated in transgender individuals who lack access to affirming care. The 2015 U.S. Transgender Survey found that 40% of respondents had attempted suicide at some point in their lifetime, compared to approximately 4.6% in the general U.S. population. Access to gender-affirming care has been associated with substantial reductions in suicidality.

Gender dysphoria frequently co-occurs with other mental health conditions. It is critical to understand that these co-occurring conditions are most often consequences of the distress caused by gender dysphoria and the social marginalization faced by transgender individuals, rather than causes or indicators of an underlying separate pathology.

Commonly co-occurring conditions include:

• Depression and anxiety disorders: These are the most frequently reported co-occurring conditions. Research suggests that rates of depression and generalized anxiety disorder are 2–4 times higher among individuals with gender dysphoria compared to cisgender populations. Rates tend to decrease significantly with access to gender-affirming treatment.
• Suicidality and self-harm: As noted above, rates of suicidal ideation, suicide attempts, and non-suicidal self-injury are disproportionately high, particularly among adolescents and those without supportive environments.
• Trauma and PTSD: Transgender individuals experience higher rates of interpersonal violence, sexual assault, and other traumatic events, leading to elevated rates of post-traumatic stress disorder.
• Autism spectrum disorder (ASD): Research has consistently found a higher co-occurrence of gender diversity and autism spectrum features. Studies estimate that gender-diverse individuals are 3–6 times more likely to have an ASD diagnosis than the general population. The reasons for this association are not fully understood and are a subject of active research. The co-occurrence does not invalidate either the gender identity or the autism diagnosis and requires integrated clinical care.
• Eating disorders and body image disturbance: Distress related to one's body in the context of gender dysphoria can manifest as disordered eating, body image disturbance, or clinically significant eating disorders. These presentations require careful differential diagnosis and integrated treatment.
• Substance use disorders: Elevated rates of substance use have been documented and are thought to relate to minority stress and coping with untreated dysphoria or social rejection.

Clinicians should assess for these conditions as part of a comprehensive evaluation and should treat them concurrently with, not as a prerequisite to, gender-affirming care. Delaying gender-affirming treatment until co-occurring conditions resolve can create a harmful cycle, as the co-occurring conditions are often driven by the untreated dysphoria itself.

If you or someone you know is experiencing persistent distress related to a discrepancy between experienced gender and assigned sex, seeking professional support is strongly recommended. This is especially important when the distress is:

• Interfering with daily functioning, including work, school, or relationships
• Accompanied by depression, anxiety, or feelings of hopelessness
• Leading to self-harm, suicidal thoughts, or substance use as a coping mechanism
• Causing significant avoidance behavior (e.g., withdrawing from social activities, avoiding healthcare appointments)
• Present in an adolescent who is approaching or undergoing puberty and expressing significant distress about physical development

Where to find help:

• A mental health professional (psychologist, psychiatrist, clinical social worker, or licensed counselor) with experience in gender identity — many providers list this as an area of specialization
• Gender identity clinics or multidisciplinary gender health programs, which are available at many academic medical centers
• Primary care providers can serve as a starting point for referrals and, in some cases, initiate hormone therapy under established protocols
• Organizations such as WPATH maintain provider directories

Crisis resources: If you or someone you know is in immediate danger or experiencing suicidal thoughts, contact the 988 Suicide and Crisis Lifeline (call or text 988 in the U.S.) or the Trans Lifeline (1-877-565-8860), which is staffed by transgender individuals. For emergencies, call 911 or go to the nearest emergency room.

Exploring one's gender identity is not inherently a crisis, and not all gender-diverse individuals require mental health treatment. However, when gender-related distress is causing suffering or functional impairment, professional support can be transformative. Evidence consistently shows that timely, affirming care leads to better outcomes.